Hematology TimesResearch explains why cisplatin causes hearing lossDecember 28, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDrug receives fast track, orphan designations for PTCLDecember 27, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesChemo-free combo should be option for rel/ref CLL, doc saysDecember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesRisk stratification may be possible with JCAR017December 21, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesPembrolizumab sBLA receives priority reviewDecember 16, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesTechnique may be effective for diagnosing NHLDecember 14, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCombo prolongs survival in lymphoma modelsDecember 1, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesInhibitor exhibits activity against range of lymphomasNovember 30, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesMogamulizumab BLA receives priority reviewNovember 29, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesHow CLL patients weigh treatment efficacy, safety, and costNovember 26, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesReview suggests low incidence of BIA-ALCL in CanadaNovember 25, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesCCSs have increased risk of hypertensionNovember 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesMethod identifies effective treatments for leukemias, lymphomasNovember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesFDA expands approval of obinutuzumabNovember 17, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCHMP wants to expand use of BV to include CTCLNovember 14, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
